世界最新医学信息文摘（连续型电子期刊）
世界最新醫學信息文摘（連續型電子期刊）
세계최신의학신식문적（련속형전자기간）
World Latest Medicine Information
2015年
47期
14-15
,共2页
临床危重%细菌感染%耐药性%临床对策
臨床危重%細菌感染%耐藥性%臨床對策
림상위중%세균감염%내약성%림상대책
clinical critical%bacterial infection%drug resistance%clinical countermeasure
目的 分析临床危重患者细菌感染的耐药性及临床对策.方法 回顾性分析我院2013年1月至2014年1月来我院ICU治疗的临床危重合并细菌感染患者130例的临床资料,对其细菌感染及耐药谱进行分析.结果 本组病例中共检出病原菌87株,其中革兰阳性球菌19株,占21.84%;革兰阴性球菌54株,占62.07%;真菌14株,占16.09%;其中嗜麦芽寡养单胞菌、鲍氏不动杆菌、洋葱伯克霍尔德菌的耐药率较低,而铜绿假单胞菌除对亚胺培南耐药率较低外,对环丙沙星和头孢哌酮/舒巴坦耐药率较高,金黄色葡萄球菌对MRAS的耐药率较高,占86.67%.结论 临床危重患者易合并多种耐药菌株,根据药敏培养结果采取相应的治疗措施,可降低其死亡率.
目的 分析臨床危重患者細菌感染的耐藥性及臨床對策.方法 迴顧性分析我院2013年1月至2014年1月來我院ICU治療的臨床危重閤併細菌感染患者130例的臨床資料,對其細菌感染及耐藥譜進行分析.結果 本組病例中共檢齣病原菌87株,其中革蘭暘性毬菌19株,佔21.84%;革蘭陰性毬菌54株,佔62.07%;真菌14株,佔16.09%;其中嗜麥芽寡養單胞菌、鮑氏不動桿菌、洋蔥伯剋霍爾德菌的耐藥率較低,而銅綠假單胞菌除對亞胺培南耐藥率較低外,對環丙沙星和頭孢哌酮/舒巴坦耐藥率較高,金黃色葡萄毬菌對MRAS的耐藥率較高,佔86.67%.結論 臨床危重患者易閤併多種耐藥菌株,根據藥敏培養結果採取相應的治療措施,可降低其死亡率.
목적 분석림상위중환자세균감염적내약성급림상대책.방법 회고성분석아원2013년1월지2014년1월래아원ICU치료적림상위중합병세균감염환자130례적림상자료,대기세균감염급내약보진행분석.결과 본조병례중공검출병원균87주,기중혁란양성구균19주,점21.84%;혁란음성구균54주,점62.07%;진균14주,점16.09%;기중기맥아과양단포균、포씨불동간균、양총백극곽이덕균적내약솔교저,이동록가단포균제대아알배남내약솔교저외,대배병사성화두포고동/서파탄내약솔교고,금황색포도구균대MRAS적내약솔교고,점86.67%.결론 림상위중환자역합병다충내약균주,근거약민배양결과채취상응적치료조시,가강저기사망솔.
Objective: to analyze the drug resistance and clinical strategy of bacterial infections in clinical critical patients. Methods: the clinical data of 130 cases of critical patients with bacterial infection in our hospital from January 2013 to January in our hospital were analyzed retrospectively. The bacterial infection and drug resistance spectrum of 2014 in our hospital were analyzed retrospectively.Results: in the group of patients with CPC pathogenic bacteria were detected in 87 strains of, including leather gram positive cocci 19 strains, accounting for 21.84%; gram negative cocci 54 strains, 62.07%; 14 strains of fungi, accounted for 16.09%; the Stenotrophomonas maltophilia, baumannii Acinetobacter, the drug resistance of Burkholderia cepacia rate lower, and Pseudomonas aeruginosa, except the low rate of imipenem resistant, to ciprofloxacin and Cefoperazone / sulbactam resistance rate is higher, Staphylococcus aureus resistant to MRAS rate is higher, 86.67%.Conclusion:the clinical critical patients are easy to be combined with a variety of drug resistant strains, according to the drug sensitivity training results to take appropriate treat-ment measures, can reduce the mortality.
